Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person Gray, Nathanael S
| Class:Id | Person:1225969 |
|---|
| _displayName | Gray, Nathanael S |
|---|
| _timestamp | 2016-12-27 23:37:35 |
|---|
| created | [InstanceEdit:1225977] Orlic-Milacic, Marija, 2011-03-03 |
|---|
| firstname | Nathanael S |
|---|
| initial | NS |
|---|
| modified | [InstanceEdit:1225980] Orlic-Milacic, Marija, 2011-03-03
[InstanceEdit:8953782] D'Eustachio, Peter, 2016-12-27 |
|---|
| surname | Gray |
|---|
| (author) | [LiteratureReference:1225967] Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
[LiteratureReference:1982030] Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer
[LiteratureReference:2460012] Functional characterization of an isoform-selective inhibitor of PI3K-p110? as a potential anticancer agent
[LiteratureReference:8956629] Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
[LiteratureReference:9657180] A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas
[LiteratureReference:9657197] A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics
[LiteratureReference:9671390] Rational design of inhibitors that bind to inactive kinase conformations
[LiteratureReference:9671452] Targeting cancer with small molecule kinase inhibitors
[LiteratureReference:9678780] Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator
[LiteratureReference:9699697] Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK |
|---|
|
[Change default viewing format]
|
No pathways have been reviewed or authored by Gray, Nathanael S (1225969)
